Evidence map›Paper›PMID 29149107›Full record

ArticleBritish journal of cancer2018

Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation.

Mikko T Nieminen, Dyah Listyarifah, Jaana Hagström, Caj Haglund, Daniel Grenier, Dan Nordström, Veli-Jukka Uitto, Marcela Hernandez, Tülay Yucel-Lindberg, Taina Tervahartiala and 2 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. MGM as a Large-Scale Pretrained Foundation Model for Microbiome Analyses in Diverse Contexts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Differences in the Oral Microbiome Between Patients With and Without Oral Squamous Cell Carcinoma.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Mikko T NieminenDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, Helsinki 00029, Finland.
Dyah ListyarifahDepartment of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Jl. Denta Sekip Utara no 1, Yogyakarta 55281, Indonesia.
Jaana HagströmDepartment of Pathology, Haartman Institute and HUSLab, University of Helsinki and Helsinki University Hospital, PO Box 21, Haartmaninkatu 3, 00014 Helsinki, Finland.
Caj HaglundResearch Program Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland.
Daniel GrenierFaculté de Médecine Dentaire, Université Laval, Quebec City, Quebec G1V 0A6, Canada.
Dan NordströmDepartment of Internal Medicine and Rehabilitation, University of Helsinki and Helsinki University Central Hospital, Helsinki 00029, Finland.
Veli-Jukka UittoDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, Helsinki 00029, Finland.
Marcela HernandezLaboratory of Periodontal Biology and Department of Oral Pathology and Medicine, Faculty of Dentistry, University of Chile, Santiago, Chile.
Tülay Yucel-LindbergDivision of Periodontology, Department of Oral Diseases, Karolinska Institutet, Box 4064, Huddinge SE-141 04, Sweden.
Taina TervahartialaDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, Helsinki 00029, Finland.
Mari AinolaDepartment of Medicine, Clinicum, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, Helsinki 00029, Finland.
Timo SorsaDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, Helsinki 00029, Finland.
University of Helsinki · FIKarolinska Institutet · SEHelsinki University Hospital · FIUniversidad Autónoma de Chile · CLUniversitas Gadjah Mada · IDUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeriodontal pathogens have been linked to oral and gastrointestinal (orodigestive) carcinogenesis. However, the exact mechanisms remain unknown. Treponema denticola (Td) is associated with severe periodontitis, a chronic inflammatory disease leading to tooth loss. The anaerobic spirochete Td is an invasive bacteria due to its major virulence factor chymotrypsin-like proteinase. Here we aimed to investigate the presence of Td chymotrypsin-like proteinase (Td-CTLP) in major orodigestive tumours and to elucidate potential mechanisms for Td to contribute to carcinogenesis.

methodsThe presence of Td-CTLP within orodigestive tumour tissues was examined using immunohistochemistry. Oral, tonsillar, and oesophageal squamous cell carcinomas, alongside gastric, pancreatic, and colon adenocarcinomas were stained with a Td-CTLP-specific antibody. Gingival tissue from periodontitis patients served as positive controls. SDS-PAGE and immunoblot were used to analyse the immumodulatory activity of Td-CTLP in vitro.

resultsTd-CTLP was present in majority of orodigestive tumour samples. Td-CTLP was found to convert pro MMP-8 and -9 into their active forms. In addition, Td-CTLP was able to degrade the proteinase inhibitors TIMP-1, TIMP-2, and α-1-antichymotrypsin, as well as complement C1q.

conclusionsBecause of its presence within tumours and regulatory activity on proteins critical for the regulation of tumour microenvironment and inflammation, the Td-CTLP may contribute to orodigestive carcinogenesis.

Indexed as

Adenocarcinomaalpha 1-AntichymotrypsinCarcinoma, Squamous CellCell Transformation, NeoplasticChymasesColonic NeoplasmsComplement C1qDigestive System NeoplasmsEsophageal NeoplasmsHead and Neck NeoplasmsHumansMatrix Metalloproteinase 8Matrix Metalloproteinase 9Mouth NeoplasmsPancreatic NeoplasmsStomach Neoplasmsalpha 1-AntichymotrypsinChymasesComplement C1qMatrix Metalloproteinase 8Matrix Metalloproteinase 9TIMP1 protein, humanTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-2

Identifiers

PMID29149107
PMCPMC5808028
OpenAlexW2770226065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.